The Wistar Institute Appoints Joseph Salvino, Ph.D., as Professor in the Molecular and Cellular Oncogenesis Program and Scientific Director of the Molecular Screening Facility
Wistar announces the appointment of Joseph M. Salvino, Ph.D., as professor in the Molecular and Cellular Oncogenesis Program and Scientific Director of the Institute’s Molecular Screening Facility.
1-Feb-2017 1:05 PM EST Add to Favorites
Wistar Scientists identified a novel protein pathway across several types of cancer that controls how tumor cells acquire the energy necessary for movement, invasion and metastasis.
16-Dec-2016 10:05 AM EST Add to Favorites
The Wistar Institute Announces GSK Visiting Professor to Promote Academic-Industry Research Collaboration, Accelerate Drug Discovery
Wistar welcomes Kenneth W. Hance, Ph.D., M.P.H., Director of Antibody Therapies, Immuno-Oncology & Combinations DPU at GlaxoSmithKline (GSK), as its first Visiting Professor from GSK at Wistar.
15-Dec-2016 9:00 AM EST Add to Favorites
The Wistar Institute Awarded Nearly $9 Million to Advance Synthetic DNA Antibody-Based Therapy to Protect Against Zika Virus
The Bill & Melinda Gates Foundation has awarded an $8,777,578 million grant to The Wistar Institute to create a preventative Zika therapy utilizing synthetic DNA monoclonal antibodies (dMAbs).
30-Nov-2016 12:00 PM EST Add to Favorites
The Wistar Institute and Man’s Best Friend Therapeutics Announce Partnership to Advance Canine Melanoma Cancer Vaccine
The Wistar Institute and Man’s Best Friend Therapeutics are pleased to announce a new collaboration that leverages Wistar’s groundbreaking vaccine research and development with MBFT’s expertise in developing animal health products.
17-Nov-2016 11:05 AM EST Add to Favorites
In this preclinical study, 100 percent of the animal models were protected from Zika after vaccination followed by a challenge with the Zika virus. In addition, they were protected from degeneration in the cerebral cortex and hippocampal areas of...
7-Nov-2016 2:00 PM EST Add to Favorites
Scientists at The Wistar Institute have demonstrated how a protein called TRAP1 – an important regulator of energy production in healthy and cancerous cells – is an important driver of prostate cancer and appears to be a valuable therapeutic...
9-Nov-2016 4:00 PM EST Add to Favorites
Researchers at The Wistar Institute have identified a protein that plays a critical role in the expression of cytokines and chemokines, and that decreasing this protein suppresses the expression of these secreted factors. This suggests that there...
27-Oct-2016 2:00 PM EDT Add to Favorites
6-Aug-2014 10:00 AM EDT
Dr. Luis Montaner, Wistar Institute HIV/AIDS Expert, Can Address His Work in the Search for a Cure, for World AIDS Day
26-Nov-2013 2:25 PM EST
22-Feb-2013 4:15 PM EST
The Winter Sun May Not Be Warm, but Still Can Be Dangerous. Wistar Melanoma Expert on Wintertime UV Risks
22-Jan-2013 2:30 PM EST